Cancer Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Cancer
Genenews Announces Management Changes
May 1st, 2007
GeneNews Limited (TSX: GEN) today announced the appointment of Dr. Ming Xu as Director, Product Development. In addition, Mr. Colin T. West, CA, currently serving as Chief Financial Officer for an interim period as previously announced, has been appointed to the position permanently as the Company's Vice President, Finance and CFO. The Equicom Group has also been retained to manage and provide investor relations services for the Company. "GeneNews has reached a critical point in its development. ColonSentry(tm), our novel blood-based test for detecting colorectal cancer, is rapidly approaching commercialization and our Sentry pipeline of additional disease-specific...
Source: Cancer Weekly (2007-05-01)
|
